Merck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor Drug

By David Sachs


Merck has a deal worth at least $70 million with Abbisko Therapeutics to commercialize a drug to treat joint tumors.

The German pharmaceutical company said Monday that its...

Related Keywords

Germany ,Macau ,Hong Kong ,China ,Taiwan ,German ,Chinese ,David Sachs ,Andrew Paterson , ,Abbisko Therapeutics ,Dow Jones ,Markets ,